Andrea I. McClatchey

This study uses quantitative imaging to analyze schwannoma heterogeneity and test drugs in a mouse model, revealing distinct therapeutic response signatures.

This study shows that restoring merlin in Nf2-deficient schwannoma cells reduces tumor growth in a genetically engineered mouse model of NF2-SWN.

This study shows that different FGFR2 mutations in cholangiocarcinoma affect biliary architecture based on the epithelial state of the cells, revealing distinct phenotypic consequences.